St Jude Medical’s Quadra Allure MP approved for use with MR scans

St Jude Medical has announced that its Quadra Allure MP cardiac resynchronisation therapy pacemaker has been approved for use with magnetic resonance (MR) technology.

The company has received European CE Mark approval for MR for the device, which features first-to-market MultiPoint Pacing technology, allowing patients to undergo full-body diagnostic MR scans of up to 1.5 Tesla for other conditions.

Dr Philip Adamson, vice-president and medical director of global research and development at St Jude Medical, said: "This new technology allows patients who have heart failure that is challenging to manage to receive more effective therapy and still be able to get an MRI for other medical conditions if needed."

Other key benefits of the device include its compatibility with the Quartet LV lead, which has four electrodes to offer maximum flexibility for different pacing configurations, as well as the SyncAV CRT software that automatically adjusts pacing based on real-time cardiac changes.

Multiple clinical trials have shown that MultiPoint Pacing technology can be particularly beneficial in patients who have not responded to traditional biventricular pacing therapy – a group that accounts for approximately one-third of all patients receiving CRT.

With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.